Company Analysis
Sign in

Evaxion A/S (EVAX)

Nasdaq: EVAX · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2020
Full chart Alerts Compare
Grade5.1
◀ Past 5.3● Present 4.3▶ Future 5.6
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

The grade of Evaxion A/S

Nine metrics read from its own filings, by tense
Headline grade
5.1/10
◀ Past5.325% of the headline
● Present4.335% of the headline
▶ Future5.640% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 7 read as filed from the record and 2 are SI estimates, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

5.3/1025% of the headline grade · 2 of 3 filed, 1 estimated

Surviving crises

as filed
8.0/10

Has it survived what it has been through?

No warning events in its filings since 2020.

weight 22% of this tense · 80th percentile among 159 sector filers · read for itself

From the record

Evaxion A/S' filings since 2020 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed
7.1/10

What has it actually done, year after year?

4 filed years; profitable in 0 of 4.

weight 45% of this tense · 71st percentile among 102 sector filers · read for its customers

From the record

Evaxion A/S' 4 filed years say what it did: it rose in 2 of 2 years; it never fell from a peak; net income was positive in 0 of 4 of those years (its annual reports).

What it rests on

  • the share of years revenue rosetop 8% of its family
  • the share of filed years with a profitbottom 31% of its family
  • the deepest fall from a revenue peak0.0%top 9% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

SI estimate
1.0/10

How has it treated the people who own it?

SI estimate 1.0/10, confidence 35 of 100 (one part).

weight 33% of this tense · 10th percentile among 146 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
Read from one part only, the share count over the years, which ranks in the bottom 10% of 146 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
What the record cannot read
Fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
How it was reasoned
one part: the share count over the years, the one part on file, ranked among 146 in its family.
Confidence
35 of 100
What would change it
A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Evaxion A/S's shareholder treatment is put at 1.0 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the bottom 10% of 146 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.

● Present

What are they doing right now?

4.3/1035% of the headline grade · 2 of 3 filed, 1 estimated

Financial health

as filed
3.6/10

Is it financially healthy right now?

ROE -45%: lost 45¢ per shareholder dollar. Leverage 40%: owes 40¢ per asset dollar.

weight 45% of this tense · 36th percentile among 147 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, Evaxion A/S lost about 45 cents for every dollar of shareholders' money. Leverage: it owed about 40 cents per dollar of assets, and net share issuance: its share count grew 497.3% over the year (the filed statements).

What it rests on

  • what it owes per dollar of assetsbottom 46% of its family
  • return on equitytop 43% of its family
  • the share count against the year beforebottom 4% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed
4.8/10

How strong is its position in its industry?

bottom 48% of 102 in its family; net margin -102.4%.

weight 22% of this tense · 48th percentile among 102 sector filers · read for its customers

From the record

Evaxion A/S' standing among 102 graded names in its industry family: revenue of $8 million in fiscal 2025 ranks in the bottom 34% by size; a net margin of -102.4% ranks in the top 37% (its annual reports).

What it rests on

  • revenue against the family$7.5Mbottom 34% of its family
  • net margin-102.4%top 37% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

SI estimate
5.0/10

What are the people in charge doing?

SI estimate 5.0/10, confidence 20 of 100 (family median).

weight 33% of this tense · 50th percentile among 130 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate
It files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-03-18 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 8 months and cannot see past it; a floor under five years is not read as years in charge, so the desk assumes the typical reading of its industry family, the median of 130 members with one.
What the record cannot read
It files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-03-18 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 8 months and cannot see past it; a floor under five years is not read as years in charge.
How it was reasoned
family median, 130 readings behind it.
Confidence
20 of 100
What would change it
Its next annual report on file with the inputs replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Evaxion A/S's leadership is put at 5.0 of 10 with a confidence of 20 of 100, because it files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-03-18 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 8 months and cannot see past it; a floor under five years is not read as years in charge, so the desk assumes the typical reading of its industry family, the median of 130 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.

▶ Future

What are they set up to do next?

5.6/1040% of the headline grade · 3 of 3 filed

Room to expand

as filed
6.2/10

How much room does it have to grow?

top 38% of 92 in its family for room to expand.

weight 33% of this tense · 62nd percentile among 92 sector filers · read for itself

From the record

Evaxion A/S' room to grow, from the newest filed statements (fiscal 2025): cash of $23 million against debt of $6 million leaves 62.3% of its assets as net cash, top 23% of its family; cash from operations less capital spending is -88.2% of revenue (top 36%); research spending of 132.5% of revenue (bottom 45%) (its annual report).

What it rests on

  • cash less debt against assets62.3%top 23% of its family
  • cash from operations less capital spending against revenue-88.2%top 36% of its family
  • research spending against revenue132.5%bottom 45% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed
3.7/10

What could actually drive growth from here?

bottom 37% of 100 in its family for growth drivers.

weight 45% of this tense · 37th percentile among 100 sector filers · read for its customers

From the record

Evaxion A/S' growth drivers, from the filed years to fiscal 2025: the newest year grew 125.2% (top 18%); research spending grew -16.4% a year (bottom 18%); capital spending grew -66.5% a year (bottom 10%) (its annual reports). Evaxion A/S tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

What it rests on

  • the newest year's revenue growth125.2%top 18% of its family
  • three-year growth of research spending-16.4%bottom 18% of its family
  • three-year growth of capital spending-66.5%bottom 10% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed
8.5/10

Did its newest year beat what its own record pointed to?

top 15% of 72 in its family for expectations against reality.

weight 22% of this tense · 85th percentile among 72 sector filers · read for its shareholders

From the record

Evaxion A/S' newest year against its own record: net income of $8 million against a prior three-year average of $19 million (top 26%); a net margin of a loss larger than its revenue against losses larger than its revenue before (top 5%) (its annual reports).

What it rests on

  • net income against the prior three years' average+59%top 26% of its family
  • net margin against its prior averageup more than 100 pointstop 5% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton EVAX · research, not advice